A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S.

Shares of Accenture plc (NYSE:ACN – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-three ...

Big data is changing the game, and data analytics companies are shaping the future of business intelligence. Amid this ...

Despite DeepSeek and Qwen 2.5 disrupting the global tech sector, investors welcomed the impressive Q4 AI revenues from ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...

Accenture (ACN) reachead $380.75 at the closing of the latest trading day, reflecting a +1.69% change compared to its last close.

The Egyptian Competition Authority (ECA) won the“Competition Policy Award” for its guidelines on vertical agreements at the fourth annual Arab Compet ...

The CyberX Summit & Awards 2025 - Qatar Edition is set to take place on February 5, 2025, in Doha, bringing together the region's top cybersecurity leaders, ...

In a report released today, Jason Kupferberg from Bank of America Securities maintained a Buy rating on Accenture (ACN – Research Report). The ...

A team from the University of Geneva and Bayer AG present their findings on the on-off retention of oligonucleotides and the ...

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Accenture (ACN – Research Report) and Itron ...

The long-awaited and elusive ceasefire between Israel and Hamas has silenced bombs and halted air raids on the Gaza Strip, ...